Breast Cancer: Combating the adverse drug reactions- A review

Breast Cancer: Combating the adverse drug reactions- A review

Registration ID: IJNRD_183202

Published ID: IJNRD2209193

DOI: http://doi.one/10.1729/Journal.31753

Saasha Vinoo , Palak Mehta

Breast cancer, metastasis, chemotherapy, hormone receptor positive breast cancer, human epidermal development factor receptor-2, triple negative breast cancer, aromatase inhibitor kinase, immunotherapy, monoclonal antibody

Abstract: Breast Cancer is the second most common cancer after skin cancer. It occurs when cells in your breast grow and divide in an uncontrolled way, creating a mass of tissue called a tumor. This review article focuses on different types, causes of breast cancer accompanied with its pathophysiology in brief and the drugs available in the market which are used to combat the adverse effects. The complete cure of cancer being very neglible, drugs available in the market try to reduce the adverse effects of cancer to enhance the longevity of life of the patient. These drugs come with a lot of adverse effects as they tend to act on normal fast proliferating cells and as a result the person not only suffers from cancer, but also a large number of other co-morbidities associated with the drug. This review tries to suggest various medicines and ways which can be employed while administrating the available drugs in order to reduce its side effects and making it more efficacious. These suggested methods to combat the adverse effects are suggestions and might not be effective in all individuals. A doctor's prescription is a must before inculcating these medicines as it may vary from patient to patient depending on their history. These are simply medicine related and improvement in lifestyle related advices, none of them include any invasive or a hospitalized way of treatment. Hence, they can target a large number of audience.

Published Paper   E-Certificate

"Breast Cancer: Combating the adverse drug reactions- A review ", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.7, Issue 9, page no.1621-1643, September-2022, Available :https://ijnrd.org/papers/IJNRD2209193.pdf

Volume 7 Issue 9, September-2022

Pages : 1621-1643

Paper Reg. ID: IJNRD_183202

Published Paper Id: IJNRD2209193

Downloads: 000121122

Research Area: Pharmacy

Country: Mumbai, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2209193.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2209193

DOI: http://doi.one/10.1729/Journal.31753

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area